| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00002030-199811000-00005 |
| P698 | PubMed publication ID | 9708403 |
| P50 | author | Jesus Blazquez | Q68273789 |
| P2093 | author name string | A Antela | |
| F Dronda | |||
| J L Casado | |||
| P Martí-Belda | |||
| R Sabido | |||
| M J Perez-Elías | |||
| C Quereda | |||
| P433 | issue | 11 | |
| P304 | page(s) | F131-5 | |
| P577 | publication date | 1998-07-01 | |
| P1433 | published in | AIDS | Q4651863 |
| P1476 | title | Predictors of long-term response to protease inhibitor therapy in a cohort of HIV-infected patients | |
| P478 | volume | 12 |
| Q33979107 | A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1 |
| Q36342062 | Approaches to antiretroviral therapy in China |
| Q40489201 | Atazanavir Plus Cobicistat: Week 48 and Week 144 Subgroup Analyses of a Phase 3, Randomized, Double-Blind, Active-Controlled Trial |
| Q30372724 | CD4 immunophenotyping in HIV infection. |
| Q56539634 | Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study |
| Q58161067 | Clinical, Immunological and Virological Evolution in Patients with CD4 T-Cell Count above 500/mm3: Is there a Benefit to Treat with Highly Active Antiretroviral Therapy (HAART)? |
| Q36191220 | Cost-effectiveness of HIV screening in patients older than 55 years of age. |
| Q33916321 | Cumulative viral load and virologic decay patterns after antiretroviral therapy in HIV-infected subjects influence CD4 recovery and AIDS |
| Q40065223 | Early virological response to HIV treatment: can we predict who is likely to experience subsequent treatment failure? Results from an observational cohort study, London, UK. |
| Q47556093 | Early virological response to HIV treatment: can we predict who is likely to experience subsequent treatment failure? Results from an observational cohort study, London, UK. |
| Q33732237 | Effect of indinavir and higher CD4+ T-cell count on viral load response after 6 months of highly active antiretroviral therapy |
| Q33803069 | Evaluating supervised HAART in late-stage HIV among drug users: a preliminary report |
| Q34967154 | HIV disease and advanced age: an increasing therapeutic challenge |
| Q54003890 | Identification of key mutations in HIV reverse transcriptase gene can influence the clinical outcome of HAART. |
| Q33836117 | Identification of novel HLA-A2-restricted human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte epitopes predicted by the HLA-A2 supertype peptide-binding motif |
| Q37497586 | Increases in duration of first highly active antiretroviral therapy over time (1996-2009) and associated factors in the Multicenter AIDS Cohort Study |
| Q58000943 | Influencia del hospital de día en los requerimientos de ingreso hospitalario de los pacientes con sida |
| Q42651713 | Limits of deep salvage antiretroviral therapy with nelfinavir plus either efavirenz or nevirapine, in highly pre-treated patients with HIV disease |
| Q34720072 | Pharmacokinetic-pharmacodynamic analysis of lopinavir-ritonavir in combination with efavirenz and two nucleoside reverse transcriptase inhibitors in extensively pretreated human immunodeficiency virus-infected patients |
| Q57878146 | Saquinavir Hard Gel Suppresses Viral Load Insufficiently in HIV-infected Patients Naive to Anti-retroviral Therapy: A Retrospective Cohort Study |
| Q73299019 | Stavudine, lamivudine and indinavir in drug abusing and non-drug abusing HIV-infected patients: adherence, side effects and efficacy |
| Q37598597 | Steady-state pharmacokinetics of a double-boosting regimen of saquinavir soft gel plus lopinavir plus minidose ritonavir in human immunodeficiency virus-infected adults |
| Q35624701 | The cost-effectiveness of counseling strategies to improve adherence to highly active antiretroviral therapy among men who have sex with men |
| Q35841783 | Update on the Virologic and Immunologic Response to Highly Active Antiretroviral Therapy |
| Q44647854 | Use of the Protease Inhibitor Saquinavir Hard Gel in Human Immunodeficiency Virus-infected Patients in the Early Period of Highly Active Antiretroviral Therapy: Does it Affect Long-term Treatment Outcome? |
| Q34537487 | Virologic and Immunologic Response to Highly Active Antiretroviral Therapy |
| Q81037629 | Virologic and immunologic response to highly active antiretroviral therapy |
| Q74800459 | [Adherence to antiretroviral therapy measured by pill count and drug serum concentrations. Variables associated with a bad adherence] |
| Q73700814 | [Rescue antiretroviral therapy] |
Search more.